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A B S T R A C T  
The incidence of COVID-19 disease is much lower in children. Because the incidence and burden of COVID-19 disease are low in children, 
vaccination should not be done primarily for their self-protection but for communities, especially parents or high-risk individuals. Therefore, 
any vaccine should be thoroughly tested and proven safe before giving it to children to respect the risk-benefit balance. 
COVID-19 IN CHILDREN 
The incidence of COVID-19 disease is lower in children. In 
addition, children generally have a shallow risk of death. 
Compared to adults, the incidence and severity of COVID-
19 illness in children is low, and regardless of its infectivity, 
their role in the spread of the disease is limited.1,2 Children 
have consistently been shown to have a lower burden of 
COVID-19 disease than adults; therefore, it did not appear 
to be a top priority for vaccination. Young children are an 
essential driver of other common respiratory viruses.3 
 
Children account for 1%–3% of COVID-19 cases diag-
nosed and have less severe illness and a better prognosis 
than adults, with infrequent deaths, primarily affecting ad-
olescents and those with significant underlying comorbidi-
ties. Early epidemiological studies suggest that children do 
not contribute much to the spread of SARS-CoV-2. 
Younger children may be less likely to be infected or trans-
mit the virus than older children or adults.4 Incidence and 
severity of COVID-19 disease in children is low.  
VACCINATING CHILDREN 
The COVID-19 vaccine must fully demonstrate safety and 
efficacy in vaccinating children and prevent complications 
and disease transmission. The already damaging effects 
of pandemics on children's routine vaccine coverage re-
quire action to limit the increased risk of vaccine-prevent-
able diseases.5 
 
In Indonesia, COVID-19 vaccination for children aged 6 to 
11 has begun. The vaccination targets reached 26.5 mil-
lion children. The implementation of this vaccination will be 
carried out gradually. The first vaccination phase will be 
carried out in provinces and districts/cities with vaccination 
coverage criteria of doses of 1 above 70% and elderly vac-
cination coverage above 60%. To date, 8.8 million people 
from 106 districts/cities from 11 provinces have met these 
criteria.6 
 
The low rates of severe illness and death associated with 
SARS-CoV-2 infection in children and adolescents sug-
gest that they should not be prioritized for vaccination dur-
ing the initial spread of the vaccine. Sars-CoV-2 vaccine 
trials have appropriately focused on adults, and safety 
data is currently limited to adults in vaccine trials, with lim-
ited data on children. In addition, large-scale post-imple-
mentation surveillance after mass immunization will be 
needed to assess the risk of rare events, including im-
mune-mediated conditions such as antibody-dependent 
enhancements in vaccinated individuals.7 
 
The obstacle faced in vaccination in children is necessary 
to include a safe and effective vaccine for minors. How-
ever, many vaccine trials currently have no plans for en-
rolling minors.8 Urgent to discuss ethical considerations re-
lated to COVID-19 vaccination in children. Because the in-
cidence and burden of COVID-19 disease are low in chil-
dren, vaccination should not be done primarily for their 
self-protection but for communities, especially parents or 
high-risk individuals. Therefore, any vaccine should be 
thoroughly tested and proven safe before giving it to chil-
dren to respect the risk-benefit balance.5 
 
The criteria that should be prioritized over others are the 
first: there should be evidence that the COVID-19 vaccine 
is safe for children with an acceptable level of risk. The 
data needed to meet these criteria often requires years of 
research.9 Without this data, it would be a mistake to con-
sider making the COVID-19 vaccine mandatory. Vaccine 
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safety is critical to maintaining public confidence in vac-
cines, and ignoring these safety criteria can have far-
reaching consequences. 
 
Four other criteria must be prioritized considering the man-
datory or absence of the COVID-19 vaccine for children. 
First, the burden of COVID-19 disease must be pretty 
enormous, at least in some populations. Second, vaccinat-
ing children should reduce the risk of disease transmis-
sion. Third, the COVID-19 vaccine must also protect chil-
dren from disease. It does not need to be 100% effective, 
but the COVID-19 vaccine should be comparable to other 
vaccines we currently need for children. Fourth, vaccines 
should be widely available, accessible, and affordable to 
all.10 
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